This company has been marked as potentially delisted and may not be actively trading. NASDAQ:THRD Third Harmonic Bio (THRD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock About Third Harmonic Bio Stock (NASDAQ:THRD) 30 days 90 days 365 days Advanced Chart Get Third Harmonic Bio alerts:Sign Up Key Stats Today's Range$5.44▼$5.5150-Day Range N/A52-Week Range N/AVolume218,713 shsAverage Volume168,074 shsMarket Capitalization$245.96 millionP/E RatioN/ADividend YieldN/APrice Target$5.00Consensus RatingHold Company Overview TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County, New Jersey. During the year ended December 31, 2011, the Company's subsidiary, TF Investments Corporation merged into TF Financial Corporation. In July 2013, the Company acquired Roebling Financial Corp, Inc. (Roebling) and its wholly-owned subsidiary, Roebling Bank. Read More Third Harmonic Bio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreTHRD MarketRank™: Third Harmonic Bio scored higher than 5% of companies evaluated by MarketBeat, and ranked 923rd out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingThird Harmonic Bio has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageThird Harmonic Bio has received no research coverage in the past 90 days.Read more about Third Harmonic Bio's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Third Harmonic Bio are expected to decrease in the coming year, from ($1.08) to ($1.09) per share.Price to Book Value per Share RatioThird Harmonic Bio has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.64% of the float of Third Harmonic Bio has been sold short.Short Interest Ratio / Days to CoverThird Harmonic Bio has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Third Harmonic Bio has recently increased by 3.50%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldThird Harmonic Bio does not currently pay a dividend.Dividend GrowthThird Harmonic Bio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.64% of the float of Third Harmonic Bio has been sold short.Short Interest Ratio / Days to CoverThird Harmonic Bio has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Third Harmonic Bio has recently increased by 3.50%, indicating that investor sentiment is decreasing. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Third Harmonic Bio this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for THRD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Third Harmonic Bio insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.80% of the stock of Third Harmonic Bio is held by insiders.Percentage Held by Institutions93.95% of the stock of Third Harmonic Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Third Harmonic Bio's insider trading history. Receive THRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Third Harmonic Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address THRD Stock News HeadlinesThird Harmonic Bio, Inc. (THRD) Cash Flow - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comThird Harmonic Bio Stock (NASDAQ:THRD), Insider Trading ActivityJuly 11, 2025 | benzinga.comTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gold analyst believes Warren Buffett is preparing to follow suit… and he’s identified one gold miner big enough to absorb a portion of Buffett’s $330B cash pile. A key filing could confirm it by August 15th — and early investors may want to act now.July 16 at 2:00 AM | Golden Portfolio (Ad)Third Harmonic Bio Inc News (THRD) - Investing.comJuly 3, 2025 | investing.comThird Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335June 12, 2025 | globenewswire.comNortheast Dominates 2025 Highest Income Rankings, Study Says: See Where Your State StandsJune 9, 2025 | msn.comThird Harmonic Bio plans to liquidate the company, sell urticaria treatmentApril 14, 2025 | msn.comThird Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s ShatteredApril 14, 2025 | msn.comSee More Headlines THRD Stock Analysis - Frequently Asked Questions How were Third Harmonic Bio's earnings last quarter? Third Harmonic Bio, Inc. (NASDAQ:THRD) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.09. When did Third Harmonic Bio IPO? Third Harmonic Bio (THRD) raised $185 million in an IPO on Thursday, September 15th 2022. The company issued 10,900,000 shares at $16.00-$18.00 per share. What other stocks do shareholders of Third Harmonic Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Third Harmonic Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF). Company Calendar Last Earnings5/08/2025Today7/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryN/A Current SymbolNASDAQ:THRD CIK921051 Webwww.thirdfedbank.com Phone+1-215-5794000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for Third Harmonic Bio$5.00 High Price Target$5.00 Low Price Target$5.00 Potential Upside/Downside-8.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$45.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-19.27% Return on Assets-18.67% Debt Debt-to-Equity RatioN/A Current Ratio54.10 Quick Ratio54.10 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.33 per share Price / Book0.86Miscellaneous Outstanding Shares45,130,000Free Float42,465,000Market Cap$245.96 million OptionableOptionable Beta2.12 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:THRD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.